By The Huffington Post News Editors

WASHINGTON — The Obama administration placed India on a special trade blacklist Wednesday, a move some public health advocates said was retaliation for the country allowing generic versions of expensive drugs preferred by the U.S. government.

The Office of the U.S. Trade Representative objected to aspects of India’s patent system in the agency’s latest Special 301 report:

Recent actions by the Indian Government, however, have raised serious questions about the innovation climate in India and risk hindering the country’s progress towards an innovation-focused economy. In the pharmaceutical sector, some innovators are facing serious challenges in securing and enforcing patents in India. The United States urges India instead to adopt policies that support both cutting-edge innovation to address important health challenges and a robust generic market.

Read More…
More on Barack Obama

Source: FULL ARTICLE at Huffington Post